When people in India think about affordable and reliable medicines of any kind, Mankind Pharma often comes to mind. Over the past 30 years, the company has created a solid reputation centered on the principles of quality, affordability and accessibility. Today, Mankind Pharma is one of the greatest Pharmaceutical companies in India which keeps on expanding its access not only at the local level but in the global market. If you want to know about mankind pharma net worth, owners, CEO, and Market capitalization then this article covers everything that you need.

Company Overview

Mankind Pharma began with a small team and a big vision back in 1995. Since then it has expanded into the 4th largest pharmaceutical company in India. The company develops, manufactures and markets medicines across acute and chronic segments, as well as popular consumer healthcare products.

Well-known brands such as Manforce, Prega News, and Gas-O-Fast have helped Mankind Pharma achieve good visibility among consumers in India.

Who Owns Mankind Pharma?

Brothers Ramesh Juneja and Rajeev Juneja co-founded Mankind Pharma and remain the principal owners. The Juneja family trusts own a majority share in the company. Their long-term vision and disciplinary leadership has played a major role in shaping the company’s growth.

As of 2025, Ramesh Juneja’s estimated net worth is about ₹27,472 crore, while Rajeev Juneja’s net worth is close to ₹26,613.5 crore, reflecting their success in building one of the most valuable pharma businesses in India.

Who Leads Mankind Pharma?

Mankind Pharma has experienced leadership. Ramesh Juneja is the Chairman of the chair and Rajeev Juneja is the Vice Chairman and Managing Director. Sheetal Arora, the current CEO handles day-to-day functioning and strategy execution. Together, this leadership team targets innovation, in-house manufacturing, and extensive distribution focusing on even rural India.

Net Worth and Market Capitalization

Mankind Pharma made its IPO into the public market in April 2023 and is trading on the NSE and BSE. The market capitalization of Mankind Pharma as on mid December 2025 is between ₹88000 crore to ₹91000 crore. This valuation demonstrates the strong confidence of investors in the company considering its consistent revenue growth and the company’s dominant position in the Indian pharmaceutical sector.

Why Mankind Pharma Stands Out

Mankind Pharma is unique because the company remains true to its word of leaving no citizen behind. The company integrates affordability with uncompromised quality and guarantees that medicines are available through their robust supply chain. With operations in more than 34 countries and 29 years of pharmaceutical excellence, Mankind Pharma remains committed to consolidating its position as one of the best trustworthy healthcare leaders across India.